These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 15976003)

  • 1. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PGE(2)-EP4 receptor is necessary for stimulation of the renin-angiotensin-aldosterone system in response to low dietary salt intake in vivo.
    Pöschke A; Kern N; Maruyama T; Pavenstädt H; Narumiya S; Jensen BL; Nüsing RM
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1435-42. PubMed ID: 22993066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat.
    Jensen BL; Mann B; Skøtt O; Kurtz A
    Kidney Int; 1999 Aug; 56(2):528-37. PubMed ID: 10432392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
    Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome.
    Nüsing RM; Seyberth HW
    Acta Physiol Scand; 2004 Aug; 181(4):523-8. PubMed ID: 15283766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
    Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
    Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
    J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Reinalter SC; Jeck N; Brochhausen C; Watzer B; Nüsing RM; Seyberth HW; Kömhoff M
    Kidney Int; 2002 Jul; 62(1):253-60. PubMed ID: 12081585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton.
    Martineau LC; McVeigh LI; Jasmin BJ; Kennedy CR
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F693-701. PubMed ID: 14665434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
    Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
    Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter.
    Pressler CA; Heinzinger J; Jeck N; Waldegger P; Pechmann U; Reinalter S; Konrad M; Beetz R; Seyberth HW; Waldegger S
    J Am Soc Nephrol; 2006 Aug; 17(8):2136-42. PubMed ID: 16807401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin receptors EP2, EP3, and IP mediate exudate formation in carrageenin-induced mouse pleurisy.
    Yuhki K; Ueno A; Naraba H; Kojima F; Ushikubi F; Narumiya S; Oh-ishi S
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1218-24. PubMed ID: 15316088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
    Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
    Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
    Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
    Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
    Jadhav V; Jabre A; Lin SZ; Lee TJ
    J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.